Wells Fargo & Company Imago Bio Sciences, Inc. Transaction History

Wells Fargo & Company

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$14.15 - $19.5 $2,264 - $3,120	-160 Reduced 35.16%	295 $4,000
Q2 2022 Aug 12, 2022	SELL	$11.81 - $20.92 $50,239 - $88,993	-4,254 Reduced 90.34%	455 $6,000
Q1 2022 May 16, 2022	SELL	$16.97 - $25.0 $19,362 - $28,525	-1,141 Reduced 19.5%	4,709 $91,000
Q4 2021 Feb 14, 2022	BUY	$16.22 - $29.69 $93,962 - $171,994	5,793 Added 10163.16%	5,850 $139,000
Q3 2021 Nov 15, 2021	BUY	$16.0 - $28.84 $912 - $1,643	57 New	57 $1,000

19.3K

Ticker IMGO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,741,600
Description
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.